Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia

Leuk Res. 2009 Aug;33(8):1147-8; author reply 1149-50. doi: 10.1016/j.leukres.2009.02.030. Epub 2009 Apr 23.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacokinetics*
  • Benzamides
  • Cytogenetic Analysis
  • Drug Monitoring
  • Female
  • Fusion Proteins, bcr-abl / analysis
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myeloid, Accelerated Phase
  • Leukemia, Myeloid, Chronic-Phase
  • Male
  • Middle Aged
  • Piperazines / administration & dosage*
  • Piperazines / pharmacokinetics*
  • Polymerase Chain Reaction
  • Pyrimidines / administration & dosage*
  • Pyrimidines / pharmacokinetics*
  • Risk Assessment

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl